S&P Futures
4,141.00 -5.75 (-0.14%) Dow Futures
32,729.00 -28.00 (-0.09%) Nasdaq Futures
13,220.75 -8.00 (-0.06%) Russell 2000 Futures
1,919.50 -2.30 (-0.12%) Crude Oil
89.53 +0.52 (+0.58%) Gold
1,788.80 -2.40 (-0.13%)
ChromaDex Corporation (CDXC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.8200 |
| Open | 1.8000 |
| Bid | 0.0000 x 1300 |
| Ask | 0.0000 x 800 |
| Day's Range | 1.7594 - 1.9500 |
| 52 Week Range | 1.5100 - 9.0400 |
| Volume | |
| Avg. Volume | 526,838 |
| Market Cap | 129.152M |
| Beta (5Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4030 |
| Earnings Date | Aug 10, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.56 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for CDXC
Related Research
- ChromaDex CorporationAnalyst Report: Herbalife Nutrition LtdHerbalife sells nutritional supplements, personal care and weight management products worldwide. Herbalife products are sold in 94 countries, and over half of sales come from outside the Americas. HLF was incorporated in the Cayman Islands in 2002 as a holding company for Herbalife International, which was founded in 1980. The operating company is headquartered in Los Angeles. With a market cap of approximately $2.9 billion, the stock is generally regarded as mid-cap growth.RatingFair ValueEconomic Moat4 days agoArgus Research
- Business Wire
ChromaDex to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
LOS ANGELES, August 02, 2022--ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed. August 10, 2022 at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.
- Simply Wall St.
Will ChromaDex (NASDAQ:CDXC) Spend Its Cash Wisely?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Business Wire
ChromaDex To Host Key Opinion Leader Webinar on the Transforming Benefits of Nicotinamide Riboside (NR)
LOS ANGELES, July 07, 2022--ChromaDex Corp. (NASDAQ:CDXC) today announced that it will host a key opinion leader (KOL) webinar on the transforming benefits of nicotinamide riboside (NR) on Wednesday, July 20, 2022 at 11:00 am Eastern Time.
